Schonfeld Strategic Advisors’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,085
| Closed | -$115K | – | 2190 |
|
|
2023
Q2 | $115K | Sell |
11,085
-12,215
| -52% | -$126K | ﹤0.01% | 1617 |
|
|
2023
Q1 | $236K | Sell |
23,300
-7,100
| -23% | -$71.9K | ﹤0.01% | 1437 |
|
|
2022
Q4 | $302K | Sell |
30,400
-11,100
| -27% | -$110K | ﹤0.01% | 1769 |
|
|
2022
Q3 | $405K | Sell |
41,500
-11,408
| -22% | -$111K | ﹤0.01% | 1863 |
|
|
2022
Q2 | $514K | Buy |
52,908
+408
| +0.8% | +$3.96K | 0.01% | 1275 |
|
|
2022
Q1 | $510K | Buy |
52,500
+2,500
| +5% | +$24.3K | ﹤0.01% | 1294 |
|
|
2021
Q4 | $484K | Buy |
50,000
+35,549
| +246% | +$344K | ﹤0.01% | 1214 |
|
|
2021
Q3 | $140K | Buy |
+14,451
| New | +$140K | ﹤0.01% | 1781 |
|